Observations on the use of haloanisone in the treatment of certain psychiatric diseases and organic psychosyndromes.
D002090:Butyrophenones; D006993:Hypnotics and Sedatives; D002537:Intracranial Arteriosclerosis; D001523:Mental Disorders; D011618:Psychotic Disorders; D013577:Syndrome
D002090:Butyrophenones; D006993:Hypnotics and Sedatives; C005014:fluanisone
CEREBRAL ARTERIOSCLEROSIS; HYPNOTICS AND SEDATIVES; PSYCHOSES